CVE-2025-22813

WordPress ChatBot Conversational Forms plugin <= 1.4.2 - Cross Site Scripting (XSS) vulnerability

Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in ChatBot for WordPress - WPBot Conversational Forms for ChatBot allows Stored XSS.This issue affects Conversational Forms for ChatBot: from n/a through 1.4.2.

Remediation

Solution:

  • Update the WordPress Conversational Forms for ChatBot wordpress plugin to the latest available version (at least 1.4.3).

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.07%
Affected: ChatBot for WordPress - WPBot Conversational Forms for ChatBot
Published at:
Updated at:

References

Link Tags
https://patchstack.com/database/wordpress/plugin/conversational-forms/vulnerability/wordpress-chatbot-conversational-forms-plugin-1-4-2-cross-site-scripting-xss-vulnerability?_s_id=cve vdb entry

Frequently Asked Questions

What is the severity of CVE-2025-22813?
CVE-2025-22813 has been scored as a medium severity vulnerability.
How to fix CVE-2025-22813?
To fix CVE-2025-22813: Update the WordPress Conversational Forms for ChatBot wordpress plugin to the latest available version (at least 1.4.3).
Is CVE-2025-22813 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-22813 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-22813?
CVE-2025-22813 affects ChatBot for WordPress - WPBot Conversational Forms for ChatBot.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.